Issue 8/2014
Content (29 Articles)
Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy
Antonino Carbone, Annunziata Gloghini, Yok-Lam Kwong, Anas Younes
Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysis
M. Port, M. Böttcher, F. Thol, A. Ganser, R. Schlenk, J. Wasem, A. Neumann, L. Pouryamout
Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis
Stefan Wöhrer, Barbara Kiesewetter, Julia Fischbach, Leonhard Müllauer, Marlene Troch, Julius Lukas, Marius E. Mayerhoefer, Markus Raderer
The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma
Abraham Avigdor, Tsvi Sirotkin, Meirav Kedmi, Elena Ribakovsy, Miriam Berkowicz, Yaron Davidovitz, Abraham Kneller, Drorit Merkel, Yulia Volchek, Tima Davidson, Elinor Goshen, Sara Apter, Avichai Shimoni, Isaac Ben-Bassat, Arnon Nagler
Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era
Samir Dalia, Julio Chavez, Bryan Little, Celeste Bello, Kate Fisher, Ji-Hyun Lee, Paul Chervenick, Lubomir Sokol, Eduardo Sotomayor, Bijal Shah
Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin’s lymphoma in Egyptians
Heba Mahmoud Gouda, Mervat Mamdooh Khorshied, Maha Hamdi El Sissy, Iman Abdel Mohsen Shaheen, Mohsen Mokhtar Abdel Mohsen
Flow cytometry CD4+CD26−CD38+ lymphocyte subset in the microenvironment of Hodgkin lymphoma-affected lymph nodes
Rosa Di Gaetano, Valentina Gasparetto, Andrea Padoan, Barbara Callegari, Laura Candiotto, Maria Colomba Sanzari, Antonio Scapinello, Giuseppe Tagariello
Mantle cell lymphoma epidemiology: a population-based study in France
Christophe Leux, Marc Maynadié, Xavier Troussard, Quentin Cabrera, Aurélie Herry, Sandra Le Guyader-Peyrou, Steven Le Gouill, Alain Monnereau
Treatment practice in the elderly patient with chronic lymphocytic leukemia—analysis of the combined SEER and Medicare database
Sacha Satram-Hoang, Carolina Reyes, Khang Q. Hoang, Faiyaz Momin, Sandra Skettino
Allogeneic stem cell transplantation in patients with de novo diffuse large B-cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a Korea–Japan collaborative study
Ji-Won Kim, Sung-Won Kim, Kohei Tada, Takahiro Fukuda, Je-Hwan Lee, Je-Jung Lee, Ji-Hyun Kwon, Soo-Mee Bang, Inho Kim, Sung-Soo Yoon, Jong Seok Lee, Seonyang Park
Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study
Sukjoong Oh, Dong Hoe Koo, Min-Jung Kwon, Kihyun Kim, Cheolwon Suh, Chang-Ki Min, Sung-Soo Yoon, Ho-Jin Shin, Deog-Yeon Jo, Jae-Yong Kwak, Jin Seok Kim, Sang Kyun Sohn, Young-Don Joo, Hyeon-Seok Eom, Sung-Hyun Kim, Yang Soo Kim, ChulSoo Kim, Yeung-Chul Mun, Hawk Kim, Dong Soon Lee, Jae Hoon Lee
Associations of VEGF and VEGFR2 polymorphisms with increased risk and aggressiveness of multiple myeloma
Angelo Borsarelli Carvalho Brito, Gustavo Jacob Lourenço, Gislaine Borba Oliveira, Cármino Antônio De Souza, José Vassallo, Carmen Silvia Passos Lima
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
Shang-Yi Huang, Chung-Wu Lin, Hsiu-Hsia Lin, Ming Yao, Jih-Luh Tang, Shang-Ju Wu, Yao-Chang Chen, Hsiao-Yun Lu, Hsin-An Hou, Chien-Yuan Chen, Wen-Chien Chou, Woei Tsay, Sheng-Je Chou, Hwei-Fang Tien
GSTT1 and GSTM1 polymorphisms predict treatment outcome for acute myeloid leukemia: a systematic review and meta-analysis
Qiang Xiao, Donghong Deng, Hongying Li, Fanghui Ye, Lulu Huang, Bing Zhang, Bingbing Ye, Zengnan Mo, Xiaobo Yang, Zhenfang Liu
Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents
Dario Ferrero, Elena Crisà, Filippo Marmont, Ernesta Audisio, Chiara Frairia, Valentina Giai, Tiziana Gatti, Moreno Festuccia, Benedetto Bruno, Ludovica Riera, Roberto Passera, Mario Boccadoro
Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial
Mariam G. Aslanyan, Leonie I. Kroeze, Saskia M. C. Langemeijer, Theresia N. Koorenhof-Scheele, Marion Massop, Patricia van Hoogen, Ellen Stevens-Linders, Louis T. van de Locht, Evelyn Tönnissen, Adrian van der Heijden, Pedro da Silva-Coelho, Daniela Cilloni, Giuseppe Saglio, Jean-Pierre Marie, Ruoping Tang, Boris Labar, Sergio Amadori, Petra Muus, Roel Willemze, Erik W. A. Marijt, Theo de Witte, Bert A. van der Reijden, Stefan Suciu, Joop H. Jansen
Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study
Caterina Tatarelli, Anna Lina Piccioni, Luca Maurillo, Virginia Naso, Roberta Battistini, Mariella D’Andrea, Marianna Criscuolo, Carolina Nobile, Nicoletta Villivà, Stefano Mancini, Benedetta Neri, Massimo Breccia, Susanna Fenu, Francesco Buccisano, Maria Teresa Voso, Roberto Latagliata, Maria Antonietta Aloe Spiriti
Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome
Carolina Cañigral, Federico Moscardó, Cristina Castro, Azucena Pajares, Aima Lancharro, Pilar Solves, Javier de la Rubia, Nelly Carpio, Miguel A. Sanz
Successful discontinuation of eculizumab therapy in a patient with aHUS
Jeffrey J. Pu, Abigail Sido
Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance
Toshiaki Yujiri, Yukinori Nakamura, Isamu Oota, Kaori Nakano, Yukio Tanizawa
Hyperammonemia, resolved by chemotherapy
N. De Maeyer, W. Meersseman, D. Dierickx, M. Delforge, J. Wauters
Hyperammonemic encephalopathy in multiple myeloma
Francesca M. E. Jones, Syed Waqas Bokhari
Diagnosis of brainstem involvement in NK/T cell lymphoma
Jason C. C. So, Koon-Ho Chan, Annie W. K. Pang, John K. F. Chan, Yok-Lam Kwong
Extramedullary T-lymphoid blast crisis of an ETV6/ABL1-positive myeloproliferative neoplasm with t(9;12)(q34;p13) and t(7;14)(p13;q11.2)
Katsuya Yamamoto, Kimikazu Yakushijin, Yuji Nakamachi, Yoshiharu Miyata, Yukinari Sanada, Yasuhiro Tanaka, Atsuo Okamura, Seiji Kawano, Yoshitake Hayashi, Hiroshi Matsuoka, Hironobu Minami
Successful vemurafenib salvage treatment in a patient with primary refractory hairy cell leukemia and pulmonary aspergillosis
Helga Maurer, Peter Haas, Tobias Wengenmayer, Michael Lübbert, Justus Duyster, Robert Zeiser
Mutant DNMT3A clone evading chemotherapy and infiltrating central nervous system in a patient with molecularly good-risk acute myeloid leukemia
Yi-Yang Chen, Cih-En Huang, Hui-Ju Chou, Pei-Shan Tsai, Chang-Hsien Lu, Miao-Fen Chen, Kuan-Der Lee, Ping-Tsung Chen, Jrhau Lung, Chih-Cheng Chen
Erratum to: Paraneoplastic disseminated intravascular coagulation caused by splenic littoral cell angioma
Marie Caroline Schlitter, Heiko Rühl, Thore Thiesler, Arndt-Hendrik Penner, Christina Berens, Dominik Wolf, Karin Mayer
Erratum to: Therapy of HIV-associated lymphoma—recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG)
Marcus Hentrich, Christian Hoffmann, Franz Mosthaf, Markus Müller, Jan Siehl, Christoph Wyen, Manfred Hensel
Erratum to: High expression of the Ets-related gene (ERG) is an independent prognostic marker for relapse-free survival in patients with acute promyelocytic leukemia
Anna Hecht, Daniel Nowak, Verena Nowak, Benjamin Hanfstein, Andreas Faldum, Thomas Büchner, Karsten Spiekermann, Cristina Sauerland, Eva Lengfelder, Wolf-Karsten Hofmann, Florian Nolte